Jiang Chuli, Zhao Yu, Zhang Wayne W, Chen Zheng, Zeng Qiu, Li Fenghe
Department of Vascular Surgery, The First Affiliated Hospital of Chongqing Medical University, China.
Division of Vascular and Endovascular Surgery, Department of Surgery, University of Washington, and Puget Sound VA Health Care System, USA.
Heliyon. 2024 May 9;10(11):e30872. doi: 10.1016/j.heliyon.2024.e30872. eCollection 2024 Jun 15.
This retrospective study aims to evaluate the safety, practicality, and efficacy of the independent retrograde popliteal approach for recanalization superficial femoral artery (SFA) occlusions when the bilateral common femoral artery approach is unavailable, such as after endovascular aneurysm repair or common iliac artery stenting.
This treatment was considered for patients with contralateral iliac artery occlusion, severe iliac tortuosity, or those who had previously undergone endovascular aneurysm repair or common iliac stenting. Patients with SFA lesions extending into the P1-P2 segment of the popliteal artery or with calcification in the P3 segment were excluded. Angioplasty and stenting were conducted via the popliteal artery approach, with hemostasis at the puncture site achieved using an EXOSEAL vascular closure device. Patients were routinely followed up at 3, 6, and 12 months, and annually thereafter.
Forty-eight consecutive patients with SFA occlusion who underwent endovascular treatment via the retrograde popliteal artery approach were included in this study. Retrograde puncture of the popliteal artery was successful in all cases. Six-French sheaths were utilized in all procedures. The EXOSEAL vascular closure device was successfully applied in all 48 cases. No instances of pseudoaneurysms, arteriovenous fistulas, major bleeding, or embolic complications were observed. The technical success rate for SFA recanalization was 100 %. All patients experienced clinical improvement. The ankle-brachial index significantly increased from an initial 0.33 ± 0.11 at admission to 0.81 ± 0.19 at discharge (P < 0.001). The mean follow-up period was 25.1 ± 11.7 months. Kaplan-Meier analysis revealed primary patency rates of 82.5 % at 12 months and 71.8 % at 24 months. No patients required major amputation during the follow-up period.
The endovascular treatment of SFA occlusions via the independent retrograde popliteal approach is a viable alternative, demonstrating a low incidence of puncture-related complications and a high success rate of recanalization.
本回顾性研究旨在评估在双侧股总动脉入路不可用时,如在血管内动脉瘤修复术或髂总动脉支架置入术后,独立逆行腘动脉入路用于再通股浅动脉(SFA)闭塞的安全性、实用性和有效性。
对患有对侧髂动脉闭塞、严重髂动脉迂曲或先前接受过血管内动脉瘤修复术或髂总动脉支架置入术的患者考虑采用这种治疗方法。排除SFA病变延伸至腘动脉P1 - P2段或P3段有钙化的患者。通过腘动脉入路进行血管成形术和支架置入术,使用EXOSEAL血管闭合装置实现穿刺部位止血。患者在3、6和12个月时进行常规随访,此后每年随访一次。
本研究纳入了48例连续通过逆行腘动脉入路接受血管内治疗的SFA闭塞患者。所有病例腘动脉逆行穿刺均成功。所有手术均使用6F鞘。EXOSEAL血管闭合装置在所有48例中均成功应用。未观察到假性动脉瘤、动静脉瘘、大出血或栓塞并发症的情况。SFA再通的技术成功率为100%。所有患者临床症状均有改善。踝肱指数从入院时的初始值0.33±0.11显著增加至出院时的0.81±0.19(P<0.001)。平均随访期为25.1±11.7个月。Kaplan - Meier分析显示12个月时的主要通畅率为82.5%,24个月时为71.8%。随访期间无患者需要进行大截肢。
通过独立逆行腘动脉入路对SFA闭塞进行血管内治疗是一种可行的替代方法,显示出穿刺相关并发症的发生率低且再通成功率高。